Melinda N. Tea

834 total citations
19 papers, 535 citations indexed

About

Melinda N. Tea is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Melinda N. Tea has authored 19 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Melinda N. Tea's work include CAR-T cell therapy research (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Melinda N. Tea is often cited by papers focused on CAR-T cell therapy research (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Melinda N. Tea collaborates with scholars based in Australia, United States and Singapore. Melinda N. Tea's co-authors include Keryn A. Williams, Stuart M. Pitson, Santosh Poonnoose, Ian L. Gibbins, Tim Chataway, Alex D. Colella, Helen M. Brereton, Lisa M. Ebert, Rebecca J. Ormsby and Douglas J. Coster and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Cell Biology and Oncogene.

In The Last Decade

Melinda N. Tea

18 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melinda N. Tea Australia 14 281 142 87 85 58 19 535
Daniel Trcka Canada 10 350 1.2× 179 1.3× 61 0.7× 80 0.9× 93 1.6× 11 659
Winson S. Ho United States 16 296 1.1× 182 1.3× 114 1.3× 173 2.0× 39 0.7× 33 724
Elke Kurz United Kingdom 11 517 1.8× 136 1.0× 157 1.8× 46 0.5× 54 0.9× 15 732
Nadine Fournier Switzerland 11 270 1.0× 165 1.2× 199 2.3× 51 0.6× 110 1.9× 25 524
Yuanzhen Suo China 14 205 0.7× 138 1.0× 69 0.8× 154 1.8× 20 0.3× 33 592
Ariane Söling Germany 15 426 1.5× 119 0.8× 153 1.8× 87 1.0× 40 0.7× 26 731
Patrick O. Azevedo Brazil 15 230 0.8× 126 0.9× 105 1.2× 40 0.5× 48 0.8× 19 605
Abdelilah Ibrahimi Belgium 10 352 1.3× 52 0.4× 74 0.9× 71 0.8× 30 0.5× 16 622
Harry Bulstrode United Kingdom 11 310 1.1× 84 0.6× 37 0.4× 57 0.7× 36 0.6× 29 544

Countries citing papers authored by Melinda N. Tea

Since Specialization
Citations

This map shows the geographic impact of Melinda N. Tea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda N. Tea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda N. Tea more than expected).

Fields of papers citing papers by Melinda N. Tea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda N. Tea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda N. Tea. The network helps show where Melinda N. Tea may publish in the future.

Co-authorship network of co-authors of Melinda N. Tea

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda N. Tea. A scholar is included among the top collaborators of Melinda N. Tea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda N. Tea. Melinda N. Tea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mekonnen, Laychiluh, Theodosia Teo, Benjamin Noll, et al.. (2025). A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma. Biomedicine & Pharmacotherapy. 189. 118340–118340.
2.
Yu, Wenbo, Nga Truong, Tessa Gargett, et al.. (2024). Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma. Clinical & Translational Immunology. 13(7). e1519–e1519. 9 indexed citations
3.
Li, Manjun, John Toubia, Melinda N. Tea, et al.. (2023). An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma. British Journal of Haematology. 204(2). 566–570. 1 indexed citations
4.
Gargett, Tessa, Lisa M. Ebert, Nga Truong, et al.. (2022). GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for ImmunoTherapy of Cancer. 10(9). e005187–e005187. 72 indexed citations
5.
Ebert, Lisa M., John Toubia, Cameron R. Bastow, et al.. (2022). Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma. Frontiers in Immunology. 13. 850226–850226. 18 indexed citations
6.
Li, Manjun, Melinda N. Tea, Melissa R. Pitman, et al.. (2021). Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition. Neoplasia. 24(1). 1–11. 13 indexed citations
7.
Tea, Melinda N., Lisa M. Ebert, Santosh Poonnoose, et al.. (2021). A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma. International Journal of Molecular Sciences. 22(9). 4322–4322. 37 indexed citations
8.
Cildir, Gökhan, John Toubia, Melinda N. Tea, et al.. (2021). 3D-printed microplate inserts for long term high-resolution imaging of live brain organoids. SHILAP Revista de lepidopterología. 3(1). 6–6. 31 indexed citations
9.
Boyle, Sarah T., Valentina Poltavets, Jasreen Kular, et al.. (2020). ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism. Nature Cell Biology. 22(7). 882–895. 52 indexed citations
10.
Tea, Melinda N., Santosh Poonnoose, & Stuart M. Pitson. (2020). Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma. Cancers. 12(1). 111–111. 38 indexed citations
11.
Neubauer, Heidi A., Melinda N. Tea, Julia R. Zebol, et al.. (2018). Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma. Oncogene. 38(8). 1151–1165. 22 indexed citations
12.
Hughes, James, Melinda N. Tea, Dale McAninch, et al.. (2017). Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling. Scientific Reports. 7(1). 12618–12618. 40 indexed citations
13.
Tea, Melinda N., Michael Michael, Helen M. Brereton, & Keryn A. Williams. (2013). Stability of small non-coding RNA reference gene expression in the rat retina during exposure to cyclic hyperoxia.. PubMed. 19. 501–8. 17 indexed citations
14.
Colella, Alex D., et al.. (2012). Comparison of Stain-Free gels with traditional immunoblot loading control methodology. Analytical Biochemistry. 430(2). 108–110. 119 indexed citations
15.
Tea, Melinda N., Rhys Fogarty, Helen M. Brereton, et al.. (2009). Gene expression microarray analysis of early oxygen-induced retinopathy in the rat. PubMed. 2(4). 190–201. 15 indexed citations
16.
Irani, Yazad, Melinda N. Tea, Ronald G. Tilton, et al.. (2008). PCR amplification of the functional immunoglobulin heavy chain variable gene from a hybridoma in the presence of two aberrant transcripts. Journal of Immunological Methods. 336(2). 246–250. 10 indexed citations
17.
Brereton, Helen M., Douglas Chamberlain, Rongchang Yang, et al.. (2007). Single chain antibody fragments for ocular use produced at high levels in a commercial wheat variety. Journal of Biotechnology. 129(3). 539–546. 15 indexed citations
18.
Yang, Runqiang, et al.. (2006). Single chain antibody fragments for ocular use produced at high levels in a commercial wheat variety. Murdoch Research Repository (Murdoch University). 4 indexed citations
19.
Turner, Marian L., Helen M. Brereton, Paul R. Badenoch, et al.. (2005). Antigens of selected Acanthamoeba species detected with monoclonal antibodies. International Journal for Parasitology. 35(9). 981–990. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Trcka Breakdown of academic impact, for papers by Winson S. Ho Breakdown of academic impact, for papers by Elke Kurz Breakdown of academic impact, for papers by Nadine Fournier Breakdown of academic impact, for papers by Yuanzhen Suo Breakdown of academic impact, for papers by Ariane Söling Breakdown of academic impact, for papers by Patrick O. Azevedo Breakdown of academic impact, for papers by Abdelilah Ibrahimi Breakdown of academic impact, for papers by Harry Bulstrode
Rankless by CCL
2026